Martin Rakusa
Overview
Explore the profile of Martin Rakusa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
372
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hochmeister S, Rakusa M, Moro E, Bereczki D, Cavallieri F, Fanciulli A, et al.
Neurol Sci
. 2025 Feb;
PMID: 39903350
Background: An online 3-item survey was sent to the European Academy of Neurology (EAN) community and inquired about the persistence of SARS-CoV-2 vaccination skepticism and the underlying thoughts and factors...
2.
Petrovcic R, Rakusa M, Markota A
Medicina (Kaunas)
. 2024 Sep;
60(9).
PMID: 39336422
Cardiac arrest remains one of the leading causes of death. After successful resuscitation of patients in cardiac arrest, post-cardiac arrest syndrome develops, part of it being an impaired cerebral blood...
3.
Filipovic S, Ozturk S, Bereczki D, Bodini B, Cavallieri F, Fanciulli A, et al.
Eur J Neurol
. 2024 Aug;
31(10):e16408.
PMID: 39088330
Background And Purpose: In October 2020, the European Academy of Neurology (EAN) consensus statement for management of patients with neurological diseases during the coronavirus disease 2019 (COVID-19) pandemic was published....
4.
Cavallieri F, Sellner J, Akhvlediani T, Bassetti C, Bereczki D, Fanciulli A, et al.
Eur J Neurol
. 2024 Apr;
32(1):e16321.
PMID: 38676302
Background: The COVID-19 pandemic has made its mark on world history forever causing millions of deaths, and straining health systems, economies, and societies worldwide. The European Academy of Neurology (EAN)...
5.
Rakusa M, Moro E, Akhvlediani T, Bereczki D, Bodini B, Cavallieri F, et al.
Eur J Neurol
. 2023 Dec;
31(3):e16168.
PMID: 38038262
Background And Purpose: The COVID-19 pandemic has significantly impacted health systems worldwide. Here, we assessed the pandemic's impact on clinical service, curricular training, and financial burden from a neurological viewpoint...
6.
Rakusa M, Chataway J, Hardy T
Pharmaceuticals (Basel)
. 2023 Sep;
16(9).
PMID: 37765052
Background: We assessed the prevalence and risks associated with pain during and after a multiple sclerosis (MS) relapse, and the impact of pain on quality of life (QoL), in MS...
7.
Rakusa M, Marolt I, Stevic Z, Rebrina S, Milenkovic T, Stepien A
Pharmaceuticals (Basel)
. 2023 Jul;
16(7).
PMID: 37513930
Introduction: Our trial (ClinicalTrials.gov Identifier: NCT04246619) evaluates the efficacy of two generic medications, pregabalin and duloxetine, for treating pain in PDPN patients. Methods: The patients were randomised either into the...
8.
Ulbl J, Rakusa M
Int J Mol Sci
. 2023 Jun;
24(12).
PMID: 37373304
Subjective cognitive decline (SCD) and mild cognitive impairment (MCI) are early stages of Alzheimer's disease (AD). Neurophysiological markers such as electroencephalography (EEG) and event-related potential (ERP) are emerging as alternatives...
9.
Bassetti C, Soffietti R, Vodusek D, Schoser B, Kuks J, Rakusa M, et al.
Eur J Neurol
. 2023 Jun;
31(3):e15909.
PMID: 37294693
Background And Purpose: Neurology residency programmes, which were first established at the beginning of the 20th century, have become mandatory all over Europe in the last 40-50 years. The first...
10.
Truini A, Aleksovska K, Anderson C, Attal N, Baron R, Bennett D, et al.
Eur J Neurol
. 2023 May;
30(8):2177-2196.
PMID: 37253688
Background And Purpose: In these guidelines, we aimed to develop evidence-based recommendations for the use of screening questionnaires and diagnostic tests in patients with neuropathic pain (NeP). Methods: We systematically...